India Circulating Tumor Cell Market
The India Circulating Tumor Cell (CTC) Market is an emerging and highly specialized segment within the nation’s oncology and molecular diagnostics landscape, primarily focused on advanced cancer management and research applications. CTCs are non-hematological cells shed from primary tumors or metastases into the peripheral blood, and their enumeration and molecular characterization offer a non-invasive "liquid biopsy" approach for disease monitoring, prognostication, and guiding treatment selection. Market growth, though currently small, is robustly driven by the increasing incidence of common cancers (breast, lung, prostate) and the growing adoption of personalized medicine in elite oncology centers. Key market determinants include the rapid influx of advanced, globally validated CTC isolation and analysis platforms (e.g., epithelial cell adhesion molecule - EpCAM based systems) and the rising number of clinical trials investigating the utility of CTCs in treatment response assessment. The advantage of liquid biopsy—its ability to capture tumor heterogeneity…